Support PenkeMerck & Co. Inc - Trending symbols
Latest News of Merck & Co. Inc
| Date | Title | Read |
|---|---|---|
| 2025-09-11 19:42 | Merck (MRK) Announces Positive Phase 3 Results For 21-Valent Pneumococcal Vaccine | Read |
| 2025-09-10 20:33 | US drugmaker scraps plans for £1bn UK research centre | Read |
| 2025-09-10 06:59 | Guggenheim Initiates Summit Therapeutics (SMMT) With a Buy Rating | Read |
| 2025-09-05 20:17 | Companies tap US bond market for nearly $70 billion, starting September on a busy note | Read |
| 2025-09-05 11:50 | Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions | Read |
| 2025-08-19 19:29 | Merck (MRK) Antibody Drug Ifinatamab Deruxtecan Gains Breakthrough Therapy Designation | Read |
| 2025-08-19 17:37 | MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer | Read |
| 2025-08-17 08:30 | Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial | Read |
| 2025-08-14 01:05 | China pharma firms turn to local reagent suppliers to cut costs and delivery times | Read |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Other Income Expense Net | 101,543 | 162,127 | 263,670 | -260,257 | 3,413 | 141,648 | 145,061 | -415,557 | -270,496 | |
| Tax Provision | 456,242 | 304,161 | 760,403 | -173,280 | 587,123 | 214,756 | 801,879 | -1,557,673 | -755,794 | |
| Income before Tax | 4,118,169 | -829,691 | 3,288,477 | -64,246 | 3,224,231 | 125,739 | 3,349,970 | -8,246,433 | -4,896,463 | |
| Net Income | 3,619,803 | -638,789 | 2,981,014 | -212,012 | 2,769,003 | -179,889 | 2,589,114 | -8,072,969 | -5,483,855 | |
| EBITDA | 4,650,493 | -882,006 | 3,768,487 | -568,118 | 3,200,369 | 292,778 | 3,493,147 | -8,093,160 | -4,600,014 | |
| Operating Income | 4,650,493 | -882,006 | 3,768,487 | -568,118 | 3,200,369 | 292,778 | 3,493,147 | -8,093,160 | -4,600,014 | |
| Net Income from Continuing Operations | 3,624,392 | -638,789 | 2,985,603 | -215,683 | 2,769,920 | -177,135 | 2,592,785 | -8,073,887 | -5,481,102 |
Comments
How you think about this?